• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Arteriovenous malformation from a patient with JP-HHT harbours two second-hit somatic DNA alterations in .一名患有少年息肉病伴遗传性出血性毛细血管扩张症(JP-HHT)的患者的动静脉畸形存在两种第二次打击体细胞DNA改变。
J Med Genet. 2025 Mar 20;62(4):281-288. doi: 10.1136/jmg-2024-110569.
2
Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT).遗传性出血性毛细血管扩张症(HHT)中毛细血管扩张和实体器官动静脉畸形形成的遗传决定因素研究。
Int J Mol Sci. 2024 Jul 12;25(14):7682. doi: 10.3390/ijms25147682.
3
Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1.遗传性出血性毛细血管扩张症血管畸形中的体细胞突变导致 ENG 或 ACVRL1 的双等位基因缺失。
Am J Hum Genet. 2019 Nov 7;105(5):894-906. doi: 10.1016/j.ajhg.2019.09.010. Epub 2019 Oct 17.
4
Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis.遗传性出血性毛细血管扩张症动静脉畸形中的体细胞突变支持发病机制的双等位基因两次打击突变机制。
Am J Hum Genet. 2024 Oct 3;111(10):2283-2298. doi: 10.1016/j.ajhg.2024.08.020. Epub 2024 Sep 18.
5
Chromosomal translocation disrupting the SMAD4 gene resulting in the combined phenotype of Juvenile polyposis syndrome and Hereditary Hemorrhagic Telangiectasia.染色体易位导致 SMAD4 基因失活,从而产生青少年息肉病综合征和遗传性出血性毛细血管扩张症的联合表型。
Mol Genet Genomic Med. 2020 Nov;8(11):e1498. doi: 10.1002/mgg3.1498. Epub 2020 Oct 15.
6
Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.ENG、ACVRL1 和 SMAD4 基因突变与遗传性出血性毛细血管扩张症的临床表现:来自乌普萨拉大学医院奥尔斯勒病中心的经验。
Ups J Med Sci. 2018 Sep;123(3):153-157. doi: 10.1080/03009734.2018.1483452. Epub 2018 Sep 25.
7
Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation.SMAD4 基因突变患者的幼年性息肉病、遗传性出血性毛细血管扩张症和结直肠癌的早发
J Gastroenterol. 2012 Jul;47(7):795-804. doi: 10.1007/s00535-012-0545-8. Epub 2012 Feb 14.
8
Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia.韩国遗传性出血性毛细血管扩张症患者ENG、ACVRL1和SMAD4基因的临床特征及突变情况
J Korean Med Sci. 2009 Feb;24(1):69-76. doi: 10.3346/jkms.2009.24.1.69. Epub 2009 Feb 28.
9
The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.ACVRL1基因c.314-35A>G多态性与伴有ENG突变的遗传性出血性毛细血管扩张症患者的器官血管畸形相关,但与伴有ACVRL1突变的患者无关。
Am J Med Genet A. 2015 Jun;167(6):1262-7. doi: 10.1002/ajmg.a.36936. Epub 2015 Apr 2.
10
An additional patient with SMAD4-Juvenile Polyposis-Hereditary hemorrhagic telangiectasia and connective tissue abnormalities: SMAD4 loss-of-function and gain-of-function pathogenic variants result in contrasting phenotypes.另一位 SMAD4-幼年性息肉病-遗传性出血性毛细血管扩张症和结缔组织异常患者:SMAD4 功能丧失和获得性功能变异导致截然不同的表型。
Am J Med Genet A. 2022 Oct;188(10):3084-3088. doi: 10.1002/ajmg.a.62915. Epub 2022 Jul 23.

引用本文的文献

1
The Role of Somatic Mutation in Hereditary Hemorrhagic Telangiectasia Pathogenesis.体细胞突变在遗传性出血性毛细血管扩张症发病机制中的作用。
J Clin Med. 2025 Jun 24;14(13):4479. doi: 10.3390/jcm14134479.

本文引用的文献

1
The UCSC Genome Browser database: 2025 update.加州大学圣克鲁兹分校基因组浏览器数据库:2025年更新
Nucleic Acids Res. 2025 Jan 6;53(D1):D1243-D1249. doi: 10.1093/nar/gkae974.
2
Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis.遗传性出血性毛细血管扩张症动静脉畸形中的体细胞突变支持发病机制的双等位基因两次打击突变机制。
Am J Hum Genet. 2024 Oct 3;111(10):2283-2298. doi: 10.1016/j.ajhg.2024.08.020. Epub 2024 Sep 18.
3
Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT).遗传性出血性毛细血管扩张症(HHT)中毛细血管扩张和实体器官动静脉畸形形成的遗传决定因素研究。
Int J Mol Sci. 2024 Jul 12;25(14):7682. doi: 10.3390/ijms25147682.
4
Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations.单细胞 DNA 测序揭示脑动静脉畸形中的隐匿性杂合性丢失。
Nat Commun. 2023 Nov 2;14(1):7009. doi: 10.1038/s41467-023-42908-w.
5
Gonomics: uniting high performance and readability for genomics with Go.基诺米克斯:用 Go 为基因组学实现高性能和易读性的统一。
Bioinformatics. 2023 Aug 1;39(8). doi: 10.1093/bioinformatics/btad516.
6
Bone Marrow-Derived Alk1 Mutant Endothelial Cells and Clonally Expanded Somatic Alk1 Mutant Endothelial Cells Contribute to the Development of Brain Arteriovenous Malformations in Mice.骨髓源性 Alk1 突变内皮细胞和克隆性扩增的体细胞 Alk1 突变内皮细胞有助于小鼠脑动静脉畸形的发展。
Transl Stroke Res. 2022 Jun;13(3):494-504. doi: 10.1007/s12975-021-00955-9. Epub 2021 Oct 21.
7
Genetic Basis and Therapies for Vascular Anomalies.血管异常的遗传基础与治疗。
Circ Res. 2021 Jun 25;129(1):155-173. doi: 10.1161/CIRCRESAHA.121.318145. Epub 2021 Jun 24.
8
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症诊断与管理的第二版国际指南。
Ann Intern Med. 2020 Dec 15;173(12):989-1001. doi: 10.7326/M20-1443. Epub 2020 Sep 8.
9
Monogenic and polygenic inheritance become instruments for clonal selection.单基因遗传和多基因遗传成为克隆选择的工具。
Nature. 2020 Aug;584(7819):136-141. doi: 10.1038/s41586-020-2430-6. Epub 2020 Jun 24.
10
Integrated Informatics Analysis of Cancer-Related Variants.癌症相关变异的综合信息学分析
JCO Clin Cancer Inform. 2020 Mar;4:310-317. doi: 10.1200/CCI.19.00132.

一名患有少年息肉病伴遗传性出血性毛细血管扩张症(JP-HHT)的患者的动静脉畸形存在两种第二次打击体细胞DNA改变。

Arteriovenous malformation from a patient with JP-HHT harbours two second-hit somatic DNA alterations in .

作者信息

DeBose-Scarlett Evon, Ressler Andrew K, Friday Cassi, Prickett Kara K, Roberts James W, Gossage James R, Marchuk Douglas A

机构信息

Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA.

Cure HHT, Monkton, Maryland, USA.

出版信息

J Med Genet. 2025 Mar 20;62(4):281-288. doi: 10.1136/jmg-2024-110569.

DOI:10.1136/jmg-2024-110569
PMID:39939156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11925654/
Abstract

BACKGROUND

Hereditary haemorrhagic telangiectasia (HHT) is an inherited disorder of vascular malformations. It is caused by inherited loss-of-function mutations in one of three genes, , or . We recently showed that HHT-associated vascular malformations from liver, lung, brain and skin develop via a two-hit genetic mechanism resulting from biallelic loss-of-function mutations in either or . Second-hit somatic mutations in have not been reported in HHT-associated vascular malformations. Here, we investigate a large, aggressively growing craniofacial arteriovenous malformation (AVM) from an individual with juvenile polyposis-HHT caused by a germline mutation in .

METHODS

We sequenced DNA from the AVM using a targeted gene sequencing panel to at least 1000X to identify somatic mutations that might contribute to the development of the AVM. We analysed whole genome SNP genotyping data using the algorithm Mosaic Chromosomal Alterations (MoChA) to identify somatic loss of heterozygosity.

RESULTS

We confirmed the germline mutation in (c.1610A>T, p.Asp537Val) and identified a second-hit somatic mutation also in (c.350dup, p.Tyr117*) that occurred in relative to the germline mutation. We also identified somatic loss of heterozygosity on the q arm of chromosome 18, including . Additionally, we confirmed that the loss of heterozygosity causes loss of the wild-type allele. Thus, we identified two independent somatic alterations in causing biallelic loss of function in the AVM tissue.

CONCLUSION

We identified biallelic loss of function of in a craniofacial AVM, evidence that also follows the two-hit mutation mechanism of HHT-associated vascular malformation pathogenesis.

摘要

背景

遗传性出血性毛细血管扩张症(HHT)是一种遗传性血管畸形疾病。它由三个基因之一、或的功能丧失性突变遗传所致。我们最近发现,肝脏、肺、脑和皮肤中与HHT相关的血管畸形是通过双打击遗传机制发展而来的,该机制由或的双等位基因功能丧失性突变引起。在与HHT相关的血管畸形中,尚未有关于的第二次打击体细胞突变的报道。在此,我们研究了一名因种系突变导致青少年息肉病 - HHT患者的一个大型、生长迅速的颅面动静脉畸形(AVM)。

方法

我们使用靶向基因测序panel对AVM的DNA进行测序,深度至少达到1000X,以鉴定可能有助于AVM发展的体细胞突变。我们使用镶嵌染色体改变(MoChA)算法分析全基因组SNP基因分型数据,以鉴定体细胞杂合性缺失。

结果

我们确认了中的种系突变(c.1610A>T,p.Asp537Val),并在中也鉴定出了第二个打击体细胞突变(c.350dup,p.Tyr117*),该突变相对于种系突变发生在中。我们还在18号染色体的q臂上鉴定出体细胞杂合性缺失,包括。此外,我们证实杂合性缺失导致野生型等位基因丢失。因此,我们在AVM组织中鉴定出导致双等位基因功能丧失的两个独立体细胞改变。

结论

我们在颅面AVM中鉴定出双等位基因功能丧失,这证明也遵循与HHT相关的血管畸形发病机制的双打击突变机制。